Tuberous sclerosis (TS) is an autosomal dominant disorder in which affected individuals manifest mental retardation, seizures, and a variety of benign and malignant tumors. The TSC2 tumor suppressor gene was recently identified by positional cloning and its protein product, tuberin, shown to represent one member of the rap GTPase activating protein (rapGAP) family. In order to determine the contribution of tuberin to the development of mental retardation and seizures in patients with TS, we examined the expression of tuberin in adult and developing nervous system tissues. Since tuberin is the second rapGAP found in the nervous system, the expression of tuberin was compared to the expression of rapGAP, rap1, and rap2. In this study, we demonstrate that tuberin is expressed at greatest levels in the spinal cord and cerebellum as opposed to rapGAP, which is not enriched in these tissues. Tuberin expression in the adult CNS is restricted to the olfactory bulb, several CNS neuronal populations, brainstem nuclei, cerebellar Purkinje cells, and motor neurons in the ventral spinal cord. In contrast, rapGAP is expressed in many different cell types in the adult CNS, but not in cerebellar Purkinje cells or motor neurons in the ventral spinal cord. However, there is significant expression of rapGAP in astrocytes. The restricted distribution of tuberin expression relative to rap1 and rapGAP suggests that tuberin may be the primary rap1 regulator in a subpopulation of CNS neurons. r 1996 Academic Press, Inc.
INTRODUCTION
Tuberous sclerosis (TS) is an autosomal dominant disorder in which affected individuals manifest benign growths or hamartomas in many tissues (Gomez, 1988; Osborn et al., 1991) . Individuals with TS develop characteristic skin lesions (adenoma sebaceum), giant cell astrocytomas, cardiac rhabdomyosarcomas, and hamartomas involving the eyes, skin, and central nervous system. In addition to the development of these tumors, mental retardation and seizures are commonly seen. Linkage analysis of affected families has demonstrated the presence of two disease-determining genes on chromosomes 9 and 16 (Jansen et al., 1991) . Individuals from families with linkage to chromosome 9q24.3 (TSC1) or chromosome 16p13.3 (TSC2) are clinically indistinguishable (Haines et al., 1991) . Genetic studies using DNA markers on chromosome 16p have demonstrated loss of heterozygosity in hamartomas from individuals affected with TS, arguing that TSC2 might be a tumor suppressor gene (Green & Yates, 1993) .
Using positional cloning strategies, the TSC2 gene was identified in 1993 and found to code for a 5.5-kb transcript widely expressed in human, mouse, and rat tissues (European Chromosome 16 Tuberous Sclerosis Consortium, 1993; Geist & Gutmann, 1995) . Loss of heterozygosity at the TSC2 locus suggested that TSC2 might be a tumor suppressor gene which was substantiated by studies on the Eker rat strain where susceptibility to renal cell carcinoma was associated with germline mutations in the rat TSC2 gene (Yeung et al., 1994; Kobayashi et al., 1995a) .
The TSC2 gene product, tuberin, encodes a protein of 1784 amino acids. A 58-residue domain at the carboxyl terminus of the protein bears sequence similarity with GTPase activating proteins (GAPs) known to regulate rap1 (rap1GAP) (European TS Consortium,
